As with the analysis comparing ALS to controls novel putative markers were present including C2 CD5, SLC39 A10, TGFBR3, SORCS3, MINPP1, SERPINA2, and PCDH11X as well as the two ER related proteins in the prior analysis. The gene discussed is SORCS3; the disease is amyotrophic lateral sclerosis.